Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.34 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | XBP1 | P17861 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29365165 | 1.00 | LMNA (0.40) | LMNAALDH1A1MAPK1TSHRCYP3A4 | |
| SCHEMBL7217044 | 0.94 | LMNA (0.42) | LMNAALDH1A1MAPK1TSHRCYP3A4 | |
| SCHEMBL18979221 | 0.92 | LMNA (0.40) | LMNAALDH1A1MAPK1TSHRCYP3A4 | |
| SCHEMBL473811 | 0.92 | LMNA (0.41) | LMNAALDH1A1MAPK1TSHRNPC1 | |
| SCHEMBL30111341 | 0.92 | LMNA (0.41) | LMNAALDH1A1MAPK1TSHRNPC1 | |
| SCHEMBL28003393 | 0.92 | LMNA (0.35) | LMNAALDH1A1MAPK1TSHRCYP3A4 | |
| SCHEMBL12802481 | 0.92 | LMNA (0.35) | LMNAALDH1A1MAPK1TSHRCYP3A4 | |
| SCHEMBL28535053 | 0.91 | LMNA (0.40) | LMNAALDH1A1MAPK1TSHRCYP3A4 | |
| SCHEMBL28344806 | 0.91 | LMNA (0.39) | LMNAALDH1A1MAPK1TSHRCYP3A4 | |
| SCHEMBL27481297 | 0.90 | LMNA (0.40) | LMNAALDH1A1MAPK1TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 519 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007110415-A2 | USE OF DIACETYL TRIMERS AND COSMETIC OR THERAPEUTIC FORMULATIONS CONTAINING THESE COMPOUNDS | SYMRISE GMBH & CO. KG (DE) | 2007-10-04 | — | — | WO | claimed |
| EP-4103144-B1 | COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2026-05-27 | — | — | EP | disclosed |
| EP-4110277-B1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2026-04-22 | — | — | EP | disclosed |
| EP-3045161-B1 | Use of active mixtures of 1,2-hexanediol and 1,2-octanediol in cosmetic, pharmaceutical or dermatological emulsions | SYMRISE AG (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4025675-B1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2026-03-18 | — | — | EP | disclosed |
| EP-4706780-A2 | COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS | Symrise AG (DE) | 2026-03-11 | — | — | EP | disclosed |
| US-20260034042-A1 | Composition with Improved SPF and UVA Photoprotection | SYMRISE AG (DE) | 2026-02-05 | — | — | US | disclosed |
| EP-4110276-B1 | COMPOSITIONS COMPRISING ALKANEDIOLS | SYMRISE AG (DE) | 2026-01-28 | — | — | EP | disclosed |
| US-12421474-B2 | Perfume oil mixture | SYMRISE AG (DE) | 2025-09-23 | — | — | US | disclosed |
| EP-4616840-A2 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION | Symrise AG (DE) | 2025-09-17 | — | — | EP | disclosed |
| WO-2005079743-A1 | USE OF (2-HYDROXYPHENYL) ALCOHOLS, AND COSMETIC OR THERAPEUTIC FORMULATIONS CONTAINING SAID COMPOUNDS | SYMRISE GMBH & CO. KG (DE) | 2005-09-01 | — | — | WO | disclosed |
| WO-2005004601-A1 | SECONDARY ALCOHOLS USED AS ANTIMICROBIAL AGENTS | SYMRISE GMBH & CO. KG (DE) | 2005-01-20 | — | — | WO | disclosed |
| EP-1326955-B1 | MULTI-PHASE SOAP | SYMRISE GMBH & CO KG (DE) | 2004-12-22 | — | — | EP | disclosed |
| EP-1466892-A1 | Novel indanylidene compounds | Symrise GmbH & Co. KG (DE) | 2004-10-13 | — | — | EP | disclosed |
| EP-1341752-B1 | NOVEL INDANYLIDENE COMPOUNDS | SYMRISE GMBH & CO KG (DE) | 2004-08-04 | — | — | EP | disclosed |
| US-6673756-B2 | MULTILAYER; CUTTING, JOINING UNDER PRESSURE | SYMRISE GMBH & CO. KG (DE) | 2004-01-06 | — | — | US | disclosed |
| US-20020173436-A1 | Multilayer; cutting, joining under pressure | SYMRISE GMBH & CO. KG (DE) | 2002-11-21 | — | — | US | disclosed |
| US-20020143203-A1 | Novel indanylidene compounds | SYMRISE GMBH & CO. KG (DE) | 2002-10-03 | — | — | US | disclosed |
| EP-1005325-A1 | COSMETIC USE OF BIS(RESORCINYL)TRIAZINE DERIVATIVES | Ciba SC Holding AG (CH) | 2000-06-07 | — | — | EP | disclosed |
| WO-1999008653-A1 | COSMETIC USE OF BIS(RESORCINYL)TRIAZINE DERIVATIVES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1999-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020143203-A1 | Novel indanylidene compounds | CUTA, NISCH, ERCC4 | LMNA 518/4885ALDH1A1 373/4885MAPK1 4474/4885 |
| US-20260034042-A1 | Composition with Improved SPF and UVA Photoprotection | TYR, ERG28, CUTA | LMNA 1465/4885ALDH1A1 1926/4885MAPK1 3052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.